S6 Kinase- and β-TrCP2-Dependent Degradation of p19Arf Is Required for Cell Proliferation

Tadashi Nakagawa1, Takaaki Araki2, Makiko Nakagawa1

  • 1Division of Cell Proliferation, ART, Graduate School of Medicine, Tohoku University, Sendai, Japan.

Insights

The mammalian target of rapamycin (mTOR) pathway promotes cell proliferation by enabling the degradation of p19Arf, a cell cycle inhibitor. This process involves S6K phosphorylation of p19Arf, targeting it for degradation via β-TrCP2.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • The mammalian target of rapamycin (mTOR) kinase regulates cell survival and proliferation, particularly under nutrient-rich conditions.
  • While mTOR's role in translation is understood, its mechanism in promoting cell proliferation remained unclear.

Purpose of the Study:

  • To elucidate the mechanism by which mTOR signaling facilitates cell proliferation.
  • To identify novel substrates of S6K involved in cell cycle regulation.

Main Methods:

  • Investigated the interaction between mTOR, S6K, and p19Arf.
  • Utilized phosphorylation site mapping (Ser75) and proteasome degradation assays.
  • Employed gene ablation of β-TrCP2 in cell cultures and mouse models.

Main Results:

  • Identified p19Arf as a novel S6K substrate phosphorylated at Ser75, promoting cell proliferation.
  • Demonstrated that phosphorylated p19Arf is specifically recognized and degraded by the F-box protein β-TrCP2.
  • Showed that ablation of β-TrCP2 leads to p19Arf accumulation and cell cycle arrest.
  • Observed embryonic lethality in β-TrCP2-deficient mice due to p19Arf accumulation.

Conclusions:

  • The mTOR pathway promotes cell proliferation by facilitating β-TrCP2-dependent degradation of the cell cycle inhibitor p19Arf.
  • This finding reveals a critical link between nutrient sensing, cell cycle control, and organismal development.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
39.0K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.4K